{"id":781464,"date":"2023-11-13T05:43:36","date_gmt":"2023-11-13T05:43:36","guid":{"rendered":"https:\/\/www.pm360online.com\/?p=781464"},"modified":"2023-11-13T05:43:36","modified_gmt":"2023-11-13T05:43:36","slug":"industry-briefs-november-2023","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/industry-briefs-november-2023\/","title":{"rendered":"Industry Briefs November 2023"},"content":{"rendered":"
The medical cannabis industry has been changing for years and while it is more widely used in a medical capacity, a new study by EO Care, Inc.<\/a> shows what kind of shift we\u2019d see in the industry if this medicinal use were covered in their health plans. After surveying employed people in parts of the U.S. where cannabis is legal, the study finds 18% of respondents have used cannabis for health reasons in the past year, but 51% would be likely\/very likely to use cannabis if it were offered by their health plan. In addition, 65% of respondents would feel more comfortable using cannabis if it were screened and dosed by a clinician.<\/p>\n \u201cFinding clinical guidance for medicinal cannabis is difficult because most doctors lack the knowledge and retail dispensaries are not equipped to provide medical advice,\u201d said Sean Collins, Co-founder and CEO of EO Care<\/a>. \u201cAs a result, we have tens of millions of Americans using cannabis for health reasons without guidance on specific product recommendations, dosage amounts, possible drug interactions, or consideration of their health history and other potential health risks. Given that sales of cannabis for health reasons is far higher than most prescription drugs, this is a highly concerning situation for healthcare generally.\u201d<\/p>\n Results showed that the most common uses for cannabis are to address anxiety, pain, and sleep issues. Additionally, 88% of medical cannabis users say it reduced their use of prescription drugs, alcohol, or both, which is a notable finding that might attract more HCPs to consider the drug as an alternative therapy and become more informed about its uses.<\/p>\n The creative engagement partner has announced the launch of a new brand called Nazar\u00e9<\/a>, a learning and capability brand. Nazar\u00e9 is combining learning, life sciences, creativity, technology, and behavioral science to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.<\/p>\nInizio Engage Launches New Brand<\/h3>\n